Awards and Recognition

The HOPA Member Awards program is an opportunity for members to recognize their HOPA colleagues who have shown outstanding achievement in their field.

John Bossaer, Vice Chair of the Recognition Committee, provides insight on the HOPA Fellows program as well as the need to recognize members with various HOPA awards. It is imperative to feature the work of oncology pharmacists to improve patient care and help bring an oncology pharmacist to every care team.

Fellow of Hematology/Oncology Pharmacy (FHOPA) Program

We are no longer accepting applications for the 2023 Fellow of HOPA and Member Awards.

A Fellow of the Hematology/Oncology Pharmacy Association (FHOPA) designation recognizes individuals who have made sustained contributions to HOPA and who have also demonstrated exceptional performance in oncology pharmacy.

Each new class of Fellows is announced at the Annual Conference.

Requirements for Consideration
Candidates for FHOPA status must be an active member of HOPA for a minimum of 10 years and must be employed for at least 10 years in an oncology related position (10 year HOPA membership may include 1 year of PGY2, excluding associate and student memberships). Additional eligibility requirements are detailed in the candidate application and include:

• Sustained contributions to HOPA
• Sustained practice contributions to the field of hematology/oncology pharmacy
• Contributions to original research
• Participation in volunteer service and/or philanthropic activities
• Nomination by two full HOPA members

Selection Process
The HOPA Recognition Committee performs a comprehensive evaluation of service to HOPA as well as practice and research accomplishments of each candidate based on information submitted in the application.
All recommended Fellows are submitted to the HOPA Board of Directors for final approval.

Application Documents

We are no longer accepting applications for the 2023 Fellow of HOPA and Member Awards.

Awards and Recognition Program

The Awards and Recognition application deadline for submissions is October 10, 2022.

Awards are presented at the Annual Members’ Meeting and Awards Presentation held each year at the HOPA Annual Conference. With the exception of the technician award, all nominees and nominators must be HOPA members.

Literature Awards

Basic Science and Clinical Research Literature Award

The HOPA Basic Science and Clinical Research Literature Award recognizes a scientific article describing hematology/oncology basic science and/or translational research or clinical trials evaluating drug efficacy and/or safety published by a HOPA member between October 1, 2021 and September 30, 2022. Examples of eligible articles include: basic research studies (ie, cellular, genetic, or animal studies), clinical trials, or pharmacokinetic or pharmacodynamic studies.

*Please note submitted articles must be published (print or electronic) by HOPA members between October 1, 2021, and September 30, 2022.

Oncology Pharmacy Practice Literature Award

The HOPA Oncology Pharmacy Practice Literature Award recognizes an article, other than scientific research, that contributes to the betterment of the hematology/oncology pharmacy profession and describes innovations in community, hospital, or healthcare system hematology/oncology pharmacy practices published by a HOPA member between October 1, 2021 and September 30, 2022. Articles should describe any aspect of professional practice including: administrative, managerial, technological, pharmacoeconomics, new practice models, clinical services, or drug use control.

*Please note submitted articles must be published (print or electronic) by HOPA members between October 1, 2021, and September 30, 2022.

To be eligible for a HOPA literature award, both the nominator and nominees must be HOPA members in good standing. The nominee must be primary, lead, or senior author and only that author may be recognized with a plaque and monetary award. Self-nominations are accepted for literature awards.

Membership Awards

The Membership Awards application deadline for submissions is October 10, 2022.

Award of Excellence

The HOPA Award of Excellence recognizes a HOPA member who has made a significant, sustained contribution to or provided excellent leadership in developing or supporting hematology/oncology pharmacy.

Diversity, Equity, and Inclusion (DEI) Award

The HOPA Diversity, Equity, and Inclusion (DEI) Award recognizes pharmacy practitioners who have demonstrated a commitment to improving DEI within HOPA, their institution, practice area, or the pharmacy profession. Their work may involve DEI initiatives, research, or advocacy and has contributed to advancements in health equity and public health, workforce or organizational diversity and inclusion, and DEI awareness, advocacy, and education. Their work has had positive impacts on oncology pharmacy practice, patients, students, or colleagues in hematology/oncology pharmacy.

New Practitioner Award

The HOPA New Practitioner Award recognizes a HOPA member early in their career who has made a significant contribution to developing or supporting clinical hematology/oncology pharmacy services.

Hematology/Oncology Technician Award

The HOPA Hematology/Oncology Technician Award recognizes a pharmacy technician who demonstrates excellence in his/her work and a commitment to hematology/oncology pharmacy practice in an organized healthcare setting. HOPA membership is NOT required.

HOPA Volunteer Award

The HOPA Volunteer Award recognizes the time, talent and energy of a HOPA member who contributes significant volunteer service to the organization through committee and/or task force contributions and representing HOPA at external events.

Leadership Award

The new HOPA Leadership Award recognizes pharmacy practitioners who have distinguished themselves by demonstrating superior leadership skills when challenged by a specific opportunity, for their institution, HOPA, or the pharmacy profession that produced/culminated in a significant outcome. As a result they will have advanced oncology pharmacy practice, or made positive changes that benefit patients, students, or colleagues in hematology/oncology pharmacy.

HOPA Patient Advocacy Award

The HOPA Patient Advocacy Award recognizes a HOPA member who demonstrates leadership and collaboration while advocating for outstanding patient care. Areas for advocacy may include

• improved patient resources
• access to care
• education or service in legislative, organizational, or community setting

The Recognition Committee will review all nominations, compile a summary of all nominations received, and make recommendations to the HOPA Board of Directors. The Recognition Committee reserves the right to recommended that no award be given. The Recognition Committee and HOPA Board of Director members who cannot judge a nomination based on their relationship with the nominee(s) are required to disclose this information and disqualify themselves from the selection process.

Current members of the HOPA Board of Directors or HOPA Recognition Committee are not eligible to nominate an individual for a membership or literature award nor are they eligible to be nominated for a membership or literature award.

If you have questions related to the HOPA Member Awards program, please email info@hoparx.org.